Molecular detection of Burkholderia pseudomallei in patients with suspected pulmonary and extra pulmonary tuberculosis.

Öz Objectives: Since melioidosis mimics tuberculosis clinically and radiologically, there is a need for a rapid diagnosticmethod to help the clinician to initiate appropriate antimicrobial treatment in order to prevent mortality. Our objectivewas to standardize a nested PCR for B. pseudomallei and its detection in pulmonary and extra pulmonary samplesfrom patients with suspected TB.Materials and Methods: Archived pulmonary and extra pulmonary samples which were negative for M. tuberculosissmear microscopy, culture and PCR were included in the study. DNA was extracted (QiAmp Blood DNA kit, Qiagen,Germany) and conventional nested PCR were carried out to detect the presence of 16S-23S spacer region of B.pseudomallei. The DNA was detected by 2% agarose gel electrophoresis and the presence of 251 bp wasconsidered positive.Results: A total of 55 samples were tested, out of which 9 (16.3%) samples tested positive for Burkholderiapseudomallei using nested PCR, which included 5 extra pulmonary and 4 pulmonary samples. These patientsbelonged to Tamil Nadu 8 (88.8%) and West Bengal 1 (11.1%) both of which are rice growing regions. Among thenine patients who were positive for B. pseudomallei by nested PCR, 2 (22%) were receiving empirical anti-tuberculartreatment (ATT). Also, these patients encountered co-morbid condition like renal failure, malignancy, diabetes andco-infection with HIV.Conclusion: We suggest that the patients with symptoms suggestive of both pulmonary and extra pulmonarytuberculosis should be routinely tested for Burkholderia pseudomallei by molecular methods for timely initiation ofappropriate therapy and avoid unnecessary exposure to ATT. J Microbiol Infect Dis 2017; 7(1): 21-28   


1. Wiersinga WJ, Currie BJ, Peacock SJ. Melioidosis. N Engl J Med 2012; 367: 1035-1044.

2. Inglis TJJ, Sagripanti J. Environmental factors that affect the survival and persistence of Burkholderia pseudomallei. Appl Environ Microbiol 2006; 72: 6865–6875.

3. Currie BJ. Burkholderia pseudomallei and Burkholderia mallei: Melioidosis and Glanders. In Mandell G, Bennet JE, Dolin R, editors. Principles and Practice of Infectious Diseases. 6th ed. New York City: Churchill Livingstone. 2005; 2622-2632.

4. Suputtamongkol Y, Chaowagul W, Chetchotisakd P, et al. Risk factors for Melioidosis and Bacteremic Melioidosis. Clin Infect Dis 1999; 29: 408-413.

5. Cheng AC, Currie BJ. Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev 2005; 18: 383-416.

6. Barani R, Sarangan G, Antony T, Periyasamy S, Kindo AJ, Srikanth P. Improved detection of Mycobacterium tuberculosis using two independent PCR targets in a tertiary care centre in south India. J Infect Dev Ctries 2012; 6: 46–52.

7. Alcântara CCSD, Kritski AL, Ferreira VG, et al. Factors associated with pulmonary tuberculosis among patients seeking medical attention at referral clinics for tuberculosis. J Bras Pneumol 2012; 38: 622-629.

8. Sankar S, Vadivel K, Nandagopal B, Jesudason MV, Sridharan G. A Multiplex nested PCR for the simultaneous detection of Salmonella typhi, Mycobacterium tuberculosis, and Burkholderia pseudomallei in patients with pyrexia of unknown origin (PUO) in Vellore, South India. Mol Diagn Ther 2014; 18: 315-321.

9. Nandagopal B, Sankar S, Lingesan K, Appu KC, Sridharan KC, Gopinathan A. Application of Polymerase Chain Reaction to detect Burkholderia Pseudomallei and Brucella species in buffy coat from patients with febrile illness among rural and peri-urban population. J Glob Infect Dis 2012; 4: 31–37.

10. Lowe P, Engler C, Norton R. Comparison of automated and nonautomated systems for identification of Burkholderia pseudomallei. J Clin Microbiol 2002; 40:4625-4627.

11. Currie BJ, Dance DA, Cheng AC. The global distribution of Burkholderia pseudomallei and melioidosis: an update. Trans R Soc Trop Med Hyg 2008; 102 Suppl 1: S1–4.

12. Gopalakrishnan R, Sureshkumar D, Thirunarayan MA, Ramasubramanian V. Melioidosis: An emerging infection in India. J Assoc Physicians India 2013; 61:612-614.

13. Currie BJ, Fisher DA, Howard DM, et al. Endemic melioidosis in tropical Northern Australia: a 10- year prospective study and review of the literature. Clin Infect Dis 2000; 31: 981-986.

14. Dance DA, Davis TM, Wattanagoon Y, et al. Acute suppurative parotitis caused by Pseudomonas pseudomallei in children. J Infect Dis 1989; 159: 654-660.

15. Caws M, Wilson SM, Clough C, Drobniewski F. Role of IS6110-targeted PCR, culture, biochemical, clinical, and immunological criteria for diagnosis of tuberculous meningitis. J Clin Microbiol 2000; 38: 3150-3155.

16. Dorman SE. New diagnostic tests for tuberculosis: bench, bedside, and beyond. Clin Infect Dis 2010; 50: S173-S177.

17. Chantratita N, Wuthiekanun V, Limmathurotsakul D, et al. Prospective clinical evaluation of the accuracy of 16S rRNA real-time PCR assay for the diagnosis of melioidosis. Am J Trop Med Hyg 2007; 77: 814-817.

18. Merritt A, Inglis TJJ, Chidlow G, Harnett G. PCRbased identification of Burkholderia pseudomallei. Rev Inst Med Trop Sao Paulo 2006; 48: 239–244.

19. Burkardt HJ. Standardization and quality control of PCR analyses. Clin Chem Lab Med 2000; 38: 87- 91.

20. Victor T, Jordaan A, du Toil R, Van Helden PD. Laboratory experience and guidelines for avoiding false positive polymerase chain reaction results. Eur J Clin Chera Clin Biochem 1993; 31: 531-535.

21. Haase A, Brennan M, Barrett S, et al. Evaluation of PCR for diagnosis of Melioidosis. J Clin Microbiol 1998; 36: 1039–1041.

22. James GL, Delaney B, Ward L, Freeman K, Mayo M, Currie BJ. Surprisingly low seroprevalence of Burkholderia pseudomallei in exposed healthy adults in the Darwin region of tropical Australia where melioidosis is highly endemic. Clin Vaccine Immunol 2013; 20: 759-760.

23. Supaprom C, Wang D, Leelayuwat C, et al. Development of Real-Time PCR assays and evaluation of their potential use for rapid detection of Burkholderia pseudomallei in clinical blood specimens. J Clin Microbiol 2007; 45: 2894–2901.